About: http://data.cimple.eu/news-article/52aab15abd78b305509f239bd6b48edb046ae3545e0f8065f4adc4b7

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/52aab15abd78b305509f239bd6b48edb046ae3545e0f8065f4adc4b7 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Swiss pharma giant Novartis reported Tuesday higher profits in the first half of the year despite the coronavirus pandemic causing swings in sales. During the first six months of the year net profit came in at $4 billion (3.5 billion euros), a 9 percent increase when currency fluctuations are stripped out. Sales rose by 6 percent from the same period last year to $23.6 billion. But the half-year figures obscure considerable swings in sales and profits due to the novel coronavirus pandemic. If sales rose by 11 percent in the first quarter as clients stocked up on medicines when the virus began to spread around the world, sales dipped by 1 percent in the second quarter. "During the second quarter, COVID-19 had an impact on our business with forward purchasing from the first quarter largely reversing," the company said in a statement. Lockdowns and the focus of medical systems on treating coronavirus and urgent patients also had an impact on the sales of certain treatments. "Sales were mostly affected by lower new patient starts and significant reduction in patient visits to physicians," said Novartis. There was also a similar evolution in quarterly earnings, with a 16 percent gain in net profit during the first three months turning into a 4 percent drop in the second quarter. Novartis said it expects mid single digit sales growth for the year, with a low double digit gain in its measure of core operating income. Over the first half of the year, core operating income rose by 19 percent. noo-rl/wdb
schema:headline	Novartis profits climb despite virus sales swings
schema:mentions	Novartis Evolution Currency Switzerland Pandemic Virus Coronavirus Coronavirus disease 2019 Earnings before interest and taxes
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-07-21 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	71 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software